Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today ...
New Platform Empowers Automakers to Shift Software Engineering Focus from Infrastructure to Innovation LAS VEGAS, NEVADA / ACCESS Newswire / January 6, 2026 / QNX, a division of BlackBerry Limited and ...
Google Cloud’s lead engineer for databases discusses the challenges of integrating databases and LLMs, the tools needed to ...
Novel capsid technology to enable convenient delivery in the doctor’s office of IKAR-003 for intermediate AMD, designed to ...
"Over the past decade, Uzbekistan’s economy has undergone an accelerated process of qualitative and systemic transformation." ...
Dosed First Patient in REVEAL Pivotal Trial in the Fourth Quarter of 2025. Additional enrollment continues to advance across ...
While in the mid-2010s the country’s nominal gross domestic product stood at approximately USD 60-65 billion, it has now ...
IonQ’s investment thesis is neutral-to-bullish, supported by a full-stack platform strategy and a $1B-plus commercial ...
Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced preliminary in ...
Paris, Jan. 06, 2026 (GLOBE NEWSWIRE) -- 88% reduction in urinary incontinence episodes in patients with neurogenic bladder sustained through ...
The company’s AI-builder approach with in-house AI innovation and bolt-on acquisitions will be key for its growth in the ...
Preliminary Preclinical Data Demonstrates In Vivo Proof-of-Concept for Novel Diabetes Gene Therapy in Type 2 Diabetic Non-Human Primates GPX-002 Rejuvenated Exhausted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback